You are viewing: China Minimally Invasive Surgery Market analysis

The China Minimally Invasive Surgery Market was valued at $9162.5 Million in 2025 and projected to reach to $21809.8 Million by 2030, representing a compound annual growth rate of 18.9%. China's minimally invasive surgery market is positioned for exceptional growth through 2030, driven by substantial healthcare investments, technological advancement, and shifting patient preferences toward less invasive treatment options.

China Minimally Invasive Surgery Market Trends and Insights

  • This represents a compound annual growth rate of 18.9%, significantly outpacing global trends.
  • China's rapid adoption of advanced surgical technologies is driven by increasing healthcare investments, rising patient demand for less invasive procedures, and expanding access to specialized surgical centers across urban and emerging markets. The Chinese market benefits from government healthcare reforms prioritizing surgical innovation and modernization of hospital infrastructure.
  • China's aging population and growing prevalence of chronic diseases are accelerating demand for minimally invasive interventions.
  • Between 2025 and 2030, China is expected to consolidate its position as a leading regional hub for surgical technology adoption, supported by domestic manufacturing capabilities and rising surgeon expertise in laparoscopic and robotic-assisted procedures..

Key Market Statistics

  • CAGR (2025-2030) 18.9% CAGR
  • Market Size, 2025 ~USD 9162.5 Million
  • Forecast, 2030 ~USD 21809.8 Million
  • Country China

China Minimally Invasive Surgery Market Overview

Exceptional Growth Trajectory :

China's minimally invasive surgery market is expanding at 18.9% CAGR, significantly outpacing the global rate of 16.1%, reflecting the country's accelerated adoption of advanced surgical technologies and healthcare modernization.

Substantial Market Valuation :

The market is valued at USD 9,162.5 million in 2025 and is projected to more than double to USD 21,809.8 million by 2030, demonstrating China's emergence as a critical hub for minimally invasive surgical innovation.

Government Healthcare Investment :

Increased government funding and healthcare infrastructure development across China are driving adoption of minimally invasive techniques, particularly in tier-2 and tier-3 cities, expanding market penetration beyond major urban centers.

Rising Patient Demand :

Growing patient preference for less invasive procedures with shorter recovery times and reduced complications is fueling demand for advanced surgical instruments and technologies across Chinese healthcare facilities.

China Minimally Invasive Surgery Market Dynamics

  • The country's expanding middle class and increasing healthcare spending are accelerating adoption of advanced surgical technologies across both public and private healthcare systems. Key growth drivers include government initiatives to modernize surgical capabilities, rising prevalence of chronic diseases requiring surgical intervention, and growing medical tourism.
  • Strategic partnerships between international medical device manufacturers and Chinese healthcare providers are facilitating technology transfer and localization, further strengthening market expansion and creating significant opportunities for stakeholders across the surgical technology ecosystem..

Related Ecosystem

Analytical And Scientific Instrumentation

Top Technologies
  • Environmental Testing
  • Gas Chromatography
  • Polymerase Chain Reaction (PCR)
  • Automated Liquid Handling Systems
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Shimadzu Corporation
  • Merck KGaA

    Cardiovascular Devices

    Top Technologies
    • External Defibrillators
    • Implantable Cardioverter Defibrillators
    • Pulse Oximeters
    • Robotic Systems
    • 3-Lead ECG Leadwires
    Top Companies
    • Medtronic plc
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Terumo Corporation
    • KONINKLIJKE PHILIPS N.V.

      Diagnostic Imaging

      Top Technologies
      • Magnetic Resonance Imaging (MRI)
      • Computed Tomography (CT)
      • CT Scanners
      • Nuclear Imaging
      • Positron Emission Tomography
      Top Companies
      • Siemens healthineers
      • PHILIPS HEALTHCARE
      • CANON INC.
      • FUJIFILM Holdings Corporation
      • UNITED IMAGING HEALTHCARE CO., LTD.

        Key Takeaways

        • China's minimally invasive surgery market will nearly double from USD 9,162.5M (2025) to USD 21,809.8M (2030), driven by 18.9% CAGR.
        • China's government healthcare reforms and infrastructure modernization are accelerating adoption of advanced surgical technologies.
        • China's aging population and rising chronic disease prevalence are key demand drivers for minimally invasive procedures through 2030.
        • China is emerging as a regional manufacturing and expertise hub, supported by domestic surgical technology production and surgeon training.

        Minimally Invasive Surgery Market Report Scope

        Report Metric Details
        Base Year 2025
        Fastest Growing Segment AMBULATORY SURGERY CENTERS (End User)
        Forecast Period 2025–2030
        Growth Rate CAGR of 16.1% from 2025 to 2030
        Largest Segment HOSPITALS (End User)
        Market Size Base Year (Billions) ~USD 94.48 (2025)
        Revenue Forecast (Billions) ~USD 199.3 (2030)
        Segments Covered Type, Application, End User, Product

        China Minimally Invasive Surgery Market Report Segmentation

        4 segment dimensions are covered across the global market.

        By Type

        • Balloon Catheters
        • Balloon Inflation Systems
        • Ct Scanners
        • Dilators
        • Electrocautery Devices
        • Electrosurgical Generators & Accessories
        • Flexible Endoscopes
        • Graspers & Dissectors
        • Guidewires
        • Guiding Catheters
        • Guiding Devices
        • Handheld Instruments
        • Inflation Systems
        • Laparoscopes
        • Laparoscopy Devices
        • Laser Fiber Devices
        • Mri Systems
        • Other Imaging & Visualization Systems
        • Probes
        • Rigid Endoscopes
        • Robotic Instruments
        • Robotic Software & Services
        • Robotic Systems
        • Suturing Instruments
        • Trocars & Cannulas
        • Tubular Retractors
        • Ultrasound Systems
        • X-Ray Systems

        By Application

        • Cardiothoracic Surgery
        • Cosmetic Surgery
        • Dental Surgery
        • Ent & Respiratory Surgery
        • Gastrointestinal & Abdominal Surgery
        • Gynecological Surgery
        • Neurological Surgery
        • Oncological Surgery
        • Orthopedic Surgery
        • Other Surgeries
        • Urological Surgery
        • Vascular Surgery

        By End User

        • Ambulatory Surgery Centers
        • Clinics
        • Emergency & Trauma Centers
        • Hospitals
        • Other End Users

        By Product

        • Electrosurgical Devices
        • Endoscopy Devices
        • Imaging & Visualization Systems
        • Medical Robotics
        • Surgical Devices

        Target Audience

        • Medical Device Manufacturers : Manufacturers of surgical instruments, endoscopes, and imaging systems need China-specific market data to develop localized product strategies, identify distribution partners, and capitalize on the 18.9% growth opportunity.
        • Healthcare Investors & PE Firms : Investment professionals evaluating opportunities in China's healthcare sector require detailed market sizing and growth projections to assess portfolio companies, identify acquisition targets, and allocate capital effectively.
        • Hospital & Healthcare Facility Operators : Chinese hospital networks and private healthcare providers need market intelligence to justify capital expenditures on surgical technology upgrades, plan service expansion, and remain competitive in minimally invasive offerings.
        • Pharmaceutical & Biotech Companies : Companies developing surgical support products, anesthetics, and post-operative care solutions require China market insights to align product launches, pricing strategies, and clinical adoption pathways.
        • Government & Policy Makers : Chinese healthcare administrators and policy officials need market data to inform healthcare infrastructure investments, technology adoption initiatives, and regulatory frameworks supporting surgical innovation.

        Key Companies in the China Minimally Invasive Surgery Market

        CompanyHQOwnershipStrongest segments
        BRUKER CORPORATIONUnited StatesPublic CompanyBSI BioSpin (NMR/EPR and preclinical imaging),BSI CALID (mass spectrometry, molecular diagnostics, automation, digital),BSI Nano (X-ray, AFM, electron microscopy tools, optical microscopy),
        MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
        JOHNSON & JOHNSONUnited StatesPublic CompanyOncology & Immunology (Innovative Medicine),Neuroscience, Cardiovascular & Metabolism, Infectious Diseases,Surgery & Interventional Solutions (MedTech),
        STRYKERUnited StatesPublic CompanyOrthopaedics Implants (Hip, Knee, Shoulder, Ankle, Trauma & Extremities),MedSurg Equipment & Patient Handling,Neurotechnology & Stroke / VTE Intervention,
        BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, single-use scopes, infection prevention),MedSurg – Urology and Pelvic Health,
        ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
        ZIMMER BIOMETUnited StatesPublic CompanyKnee and Hip Reconstructive Products,S.E.T. (Sports Medicine, Extremities, Trauma, CMF/T),Digital, Robotic, and Enabling Technologies (ROSA, ZBEdge, Bone Cement, Surgical Products),
        GLOBUS MEDICALUnited StatesPublic CompanySpine fusion implants (pedicle screw and rod, plating, interbody, corpectomy),Motion preservation and interventional spine (disc replacement, dynamic stabilization, VCF solutions),Biologic solutions and HCT/P distribution,
        INTEGRA LIFESCIENCES CORPORATIONUnited StatesPublic CompanyCodman Specialty Surgical (neurosurgery and neurocritical care),Tissue Technologies – acute and chronic wound care,Tissue Technologies – surgical reconstruction and nerve/tendon repair,
        SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
        FUJIFILM CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductor, functional films, storage, industrial equipment),Business Innovation (office equipment, document services, graphic communications),
        KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnostic Imaging (MRI, CT, X-ray, Ultrasound),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory),Image Guided Therapy Systems & Devices,
        GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),

        BRUKER CORPORATION

        Bruker Corporation is a U.S.-based public company founded in 1960 that employs 11,085 people. The company specializes in scientific instruments and analytical solutions.

        MEDTRONIC

        Medtronic is a public company headquartered in Ireland, founded in 1949, with 95,000 employees. It is a global leader in medical technology, services, and solutions.

        JOHNSON & JOHNSON

        Johnson & Johnson is a U.S.-based public company founded in 1886 with 138,200 employees. It operates across pharmaceuticals, medical devices, and consumer health products.

        STRYKER

        Stryker is a U.S. public company founded in 1941 with 56,000 employees. It is a leading provider of medical devices and software for orthopedic, surgical, and neurotechnology markets.

        BOSTON SCIENTIFIC CORPORATION

        Boston Scientific Corporation is a U.S. public company founded in 1979 with 59,000 employees. It develops and manufactures medical devices for interventional medicine and patient monitoring.

        ABBOTT

        Abbott is a U.S. public company founded in 1888 with 115,000 employees. It operates in diagnostics, medical devices, nutrition, and branded generic pharmaceuticals.

        ZIMMER BIOMET

        Zimmer Biomet is a U.S. public company founded in 1927 with 17,000 employees. It specializes in orthopedic implants, surgical products, and musculoskeletal healthcare solutions.

        GLOBUS MEDICAL

        Globus Medical is a U.S. public company founded in 2003 with 6,000 employees. It develops and manufactures musculoskeletal implants and surgical instruments.

        INTEGRA LIFESCIENCES CORPORATION

        Integra LifeSciences Corporation is a U.S. public company founded in 1989 with 4,427 employees. It provides surgical implants, instruments, and regenerative medicine products.

        SIEMENS HEALTHINEERS AG

        Siemens Healthineers AG is a German public company founded in 1896 with 72,369 employees. It offers diagnostic imaging, laboratory diagnostics, and point-of-care testing solutions.

        FUJIFILM CORPORATION

        Fujifilm Corporation is a Japanese public company founded in 1934 with 73,526 employees. It operates across imaging, information, and document solutions, including healthcare technologies.

        KONINKLIJKE PHILIPS N.V.

        Koninklijke Philips N.V. is a Dutch public company founded in 1891 with 64,317 employees. It provides health technology solutions including diagnostic imaging, patient monitoring, and connected care.

        GE HEALTHCARE

        GE Healthcare is a U.S. public company founded in 2022 with 54,000 employees. It provides medical imaging, monitoring, and diagnostic equipment and software solutions.

        Reasons to Buy this Report

        • Market Size & Growth Validation : Obtain precise market valuation data for China (USD 9,162.5M in 2025) with verified 18.9% CAGR projections through 2030, enabling accurate financial forecasting and investment decision-making in this high-growth market.
        • Competitive Intelligence : Identify key market players, technology leaders, and emerging competitors specifically operating in China's minimally invasive surgery sector to benchmark competitive positioning and market share dynamics.
        • Regional Market Segmentation : Access detailed insights into China's geographic market variations, tier-1 vs. tier-2/3 city adoption rates, and regional healthcare infrastructure differences to optimize market entry and expansion strategies.
        • Technology & Innovation Trends : Understand which minimally invasive surgical technologies are gaining traction in China, including robotic surgery, endoscopic systems, and imaging solutions, to align product development and commercialization efforts.
        • Strategic Partnership Opportunities : Identify collaboration and distribution opportunities with Chinese healthcare providers, medical device manufacturers, and government health agencies to accelerate market penetration and revenue growth.

        Frequently asked questions

        What is the projected market size of minimally invasive surgery in China by 2030?

        China's minimally invasive surgery market is projected to reach USD 21,809.8 million by 2030, up from USD 9,162.5 million in 2025.

        What is the CAGR for China's minimally invasive surgery market?

        China's minimally invasive surgery market is expected to grow at a compound annual growth rate of 18.9% between 2025 and 2030.

        What factors are driving growth in China's minimally invasive surgery market?

        Key drivers include government healthcare reforms, hospital infrastructure modernization, an aging population, rising chronic disease prevalence, and increased patient demand for less invasive procedures.

        How does China's market growth compare to global trends?

        China's 18.9% CAGR significantly outpaces the global minimally invasive surgery market CAGR of 16.1%, reflecting stronger regional demand and investment.

        What role does China play in the Asia Pacific minimally invasive surgery market?

        China is a leading market within Asia Pacific, driving regional growth through technological adoption, domestic manufacturing capabilities, and expanding surgical expertise.

        RESEARCH METHODOLOGY

        The study involved key activities in estimating the current size of the minimally invasive surgery market. Extensive secondary research was conducted to gather information on the industry. The next step was to validate these findings, assumptions, and market size with industry experts across the value chain through primary research. Different methods, such as top-down and bottom-up approaches, were used to estimate the overall market size. Subsequently, market segmentation and data triangulation techniques were applied to determine the size of various segments and subsegments within the MIS market.

        Secondary Research

        The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global minimally invasive surgery market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

        Primary Research

        During the primary research process, various sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from various companies and organizations in the minimally invasive surgery market. On the demand side, primary sources include ambulatory surgical centers, hospitals, clinics, and other end users. The primary research was conducted to validate market segmentation, identify key players, and gather insights on important industry trends and market dynamics.

        A breakdown of the primary respondents is provided below:

        Minimally Invasive Surgery Market

        *C-level primaries include CEOs, CFOs, COOs, and VPs.

        Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

        Note: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = USD 1.00 billion.

        Source: MarketsandMarkets Analysis

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        For the global market value, annual revenues were estimated based on revenue mapping of leading product manufacturers and OEMs active in the worldwide minimally invasive surgery market. All major product manufacturers were identified at the global and/or country or regional level. Revenue mapping for the respective business segments or sub-segments was performed for the key players. Also, the global minimally invasive surgery market was split into various segments and sub-segments based on:

        • List of major players operating in the product market at the regional and/or country level
        • Product mapping of various minimally invasive surgery manufacturers at the regional and/or country level
        • Mapping of annual revenue generated by listed major players from minimally invasive surgery (or the nearest reported business unit/product category)
        • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
        • Summation of the market value of all segments/subsegments to arrive at the global minimally invasive surgery market

        The data mentioned above was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

        Minimally Invasive Surgery Market

        Data Triangulation

        After determining the overall size of the global minimally invasive surgery market using the methodology mentioned above, the market was divided into several segments and subsegments. Data triangulation and market breakdown techniques were used, where applicable, to complete the overall market analysis and obtain precise market value data for the key segments and subsegments. The extrapolated market data was then triangulated by examining various macro indicators and regional trends from both demand- and supply-side participants.

        Market Definition

        Minimally invasive surgery (MIS) is a procedure that causes little to no trauma or injury to a patient. MIS is performed through a cannula using lasers, endoscopes, or laparoscopes. It involves less bleeding, reduced anesthesia, less pain, and minimal scarring compared to other procedures. The surgical instruments used to make tiny incisions and carry out MIS are minimally invasive. The primary products used for minimally invasive surgery are surgical tools, imaging and visualization systems, electrosurgical devices, endoscopy devices, and medical robotics.

        Stakeholders

        • Manufacturers and Distributors of Minimally Invasive Surgical Instruments
        • Healthcare Institutions (Hospitals and Clinics)
        • Ambulatory Surgery Centers (ASCs)
        • Healthcare Institutions (hospitals and outpatient clinics)
        • Research Institutions
        • Research and Consulting Firms
        • Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)
        • Academic Medical Centers and Universities
        • Market Research and Consulting Firms
        • Clinical Research Organizations
        • Research Laboratories and Academic Institutes
        • Minimally Invasive Surgical Instrument Service Providers

        Report Objectives

        • To describe, analyze, and forecast the minimally invasive surgery market by product, application, end user, and region
        • To describe and forecast the minimally invasive surgery market in key regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
        • To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the market growth
        • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
        • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
        • To profile key players and comprehensively analyze their market shares and core competencies2 in the minimally invasive surgery market
        • To analyze competitive developments such as partnerships, agreements & acquisitions, product launches, product approvals, and expansions in the minimally invasive surgery market
        • To analyze the impact of AI/Gen AI on the minimally invasive surgery market in terms of its capabilities, potential, use cases, and future

        Available customizations:

        With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

        Geographic Analysis

        • Further breakdown of the Rest of European minimally invasive surgery market into Russia, Switzerland, Denmark, Austria, and others
        • Further breakdown of the Rest of Asia Pacific minimally invasive surgery market into South Korea, Taiwan, and others
        • Further breakdown of the Rest of Latin American minimally invasive surgery market into Argentina, Colombia, Chile, Ecuador, and others
        • Further breakdown of the Southeast Asian minimally invasive surgery market into Malaysia, Singapore, Australia, New Zealand, and others

        Competitive Landscape Assessment

        • Market share analysis, by region (North America and Europe), which provides market shares of the top 3–5 key players in the minimally invasive surgery market
        • Competitive leadership mapping for established players in the US

        Get the Full Minimally Invasive Surgery Market Report

        Full forecast, segment splits, and company analysis for all Minimally Invasive Surgery Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status